CVS Caremark announced on May 1, 2025 that AOM tirzepatide (sold as Zepbound) would be removed from its standard preferred formulary effective July 1, 2025 ( 2 , 3 )
As PTDM and chronic kidney disease are prevalent comorbidities in liver transplant patients, and with the increasing trend of obesity, it is crucial to further investigate and understand the potential benefits and challenges of utilizing GLP-1 RAs and SGLT-2 inhibitors in this population
I also appreciated that each meal felt relatively balanced, often made up of some sort of protein, plus one carb and one vegetable side
Activation of SSAT1/ALOX15 axis aggravates cerebral ischemia/reperfusion injury via triggering neuronal ferroptosis
Types of electrolyte products Electrolyte powder packets
All biochemical species with at least one significant contrast are labeled as entities and studied further